Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $3.81 | Prev. Close $4.00 | Circuit Range N/A |
Day Range $3.81 - $4.06 | Year Range $0.24 - $5.10 | Volume 12,224 |
Average Traded $3.97 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
21-Jan-26 | $3.76 | $3.80 | -3.68% |
20-Jan-26 | $3.60 | $3.94 | +5.34% |
16-Jan-26 | $3.67 | $3.75 | -1.45% |
15-Jan-26 | $3.77 | $3.80 | -1.17% |
14-Jan-26 | $3.98 | $3.85 | -5.16% |
13-Jan-26 | $4.13 | $4.05 | -1.84% |
12-Jan-26 | $4.26 | $4.13 | -3.95% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?